Timeline

A timeline of PACCARB-related key events is listed below. A few other select events in the fight against antibiotic-resistance are also included, both domestically and internationally.


2021

June public meeting: PACCARB meets to focus on vote and deliberate on two reports from the Antibiotic Access and Use WG* and the Inter-Professional Education WG*. Presentations also focused on operationalizing One Health and the environmental dimensions of AMR.

February public meeting: PACCARB meets to focus on priority areas as identified by the Antibiotic Access and Use WG and the Inter-Professional Education WG created in response to a task letter from the Assistant Secretary for Health.


2020

September public meeting: PACCARB meets to discuss the impact of COVID-19 and its effect on antimicrobial resistance (AMR).

February HHS-hosted Listening Sessions: The February HHS-hosted AMR Listening Sessions included topics on the current landscape of antibiotic resistance and the development of alternatives, including other One Health focused panel presentations and participant discussions.


2019

July public meeting: PACCARB meets to deliberate and vote on the National Action Plan on CARB 2019 Workgroup's report out on their draft response to the Secretary of HHS on identifying priority areas for the next iteration of the National Action Plan on CARB, 2020-2025, in addition to addition to panel presentations and council discussion surrounding antifungals and educational solutions to antibiotic stewardship.

April public meeting: PACCARB meets to deliberate and vote on a one-page report drafted by the Immediate Action Subcommittee.

January public meeting: PACCARB meets to focus on priority areas that have emerged since the original National Action Plan on Combating Antibiotic Resistant Bacteria (CARB) that was launched in 2015.


2018

September public meeting: PACCARB meets to deliberate and vote on the Infection Prevention and Stewardship Working Group's report with recommendations, in addition to panel presentations and council discussion surrounding antibiotic-resistance, the environment, and One Health.

May public meeting: PACCARB meets to focus on the topic of antibiotic stewardship for animal and plant health.

March public meeting: PACCARB meets via teleconference to deliberate and vote on two letters with recommendations drafted by the Immediate Action Subcommittee, Resolution 1  and Resolution 2.


2017

September public meeting: PACCARB meets to discuss the topic of Stewardship of Antibiotic Prescription Behavior and Use and deliberates and votes on the findings and recommendations in their second report, Recommendations for Incentivizing the Development of Vaccines, Diagnostics, and Therapeutics to Combat Antibiotic-Resistance as presented by three working groups on Incentives.  Additionally, federal agencies provide updates on their achievements as stipulated in the goals with corresponding objectives and milestones of the National Action Plan (NAP) for CARB.

May public meeting: PACCARB meets to discuss infection prevention and control for animal health. Additionally, the three working groups on Incentives for Diagnostics, Therapeutics/Anti-Infectives, and Vaccines, report their preliminary findings to the full Advisory Council for deliberation; no vote is held.

January public meeting: PACCARB meets to discuss presentations from stakeholders surrounding the topic area of antibiotic-resistant infection prevention and control in human health.


2016

 United Nations holds a one-day high-level meeting to discuss "Antimicrobial Resistance," the first of its kind. The main goal of the meeting is to create and maintain strong national, regional, and international political commitment to addressing the issue of antimicrobial resistance while also raising awareness of the problem.

September public meeting: PACCARB meets to discuss antibiotic resistance prevention and antibiotic stewardship, including innovative ways to address these issues.

June public meeting: PACCARB initiates work on the March 25th task to determine the best way to incentivize the development of therapeutics (including alternatives to antibiotics), rapid diagnostics, and vaccines for both humans and animals while maximizing the return on investment, and still encouraging appropriate stewardship, and access to products.

March public meeting: PACCARB deliberates and votes on the working groups' findings and recommendations found in their first report, Initial Assessments of the National Action Plan for Combating Antibiotic-Resistant Bacteria. In addition, the PACCARB is presented with new tasks from the Secretary of The U.S. Department of Health and Human Services (HHS), in consultation with the U.S. Department of Agriculture (USDA) and the U.S. Department of Defense (DoD).


2015

White House submits First 180 Days Report on the implementation of the Year 1 milestones in the National Action Plan (NAP) for CARB.

PACCARB holds its Inaugural public meeting for all newly appointed members.

HHS/USDA/DoD announces the establishment of the PACCARB in a joint press release.

White House releases National Action Plan (NAP) for CARB.


2014

 President's Council of Advisors on Science and Technology (PCAST) Report to the President on Combating Antibiotic Resistance offers practical recommendations to the Federal government for strengthening the Nation's ability to combat the rise in antibiotic resistant bacteria.

Executive Order 13676 directs federal agencies to implement the recommendations from the PCAST report, which includes creation of a federal interagency Task Force on Combating Antibiotic-Resistant Bacteria, and requires establishment of the PACCARB.

White House releases National Strategy on Combating Antibiotic Resistant Bacteria (CARB).


2013

Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) declare antibiotic resistance to be one of the most serious problems facing our national and global health systems today.

WHO announces that antibiotic resistance is a rapidly evolving health issue extending far beyond the human health sector, and declares it a threat to global health security at the 66th World Health Assembly.

CDC gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health in their report, Antibiotic resistance threats in the United States, 2013.

*People using assistive technology may not be able to fully access information in these files. For assistance, contact the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria by emailing [email protected].

Content created by Assistant Secretary for Health (ASH)
Content last reviewed